After raising the wrath of its own social network back in October over the lack of female representation on its board, Twitter has finally appointed its first female board member: former Pearson CEO Marjorie Scardino.
Dublin: 07.12.2013 01.46AM
Some 50 new research, development and innovation projects are to be created at ResMed’s research operations at UCD in what will rank among the most comprehensive medical device development projects ever undertaken by a multinational company’s in Ireland.
ResMed Inc., a global leader in the development, manufacturing and marketing of medical products to combat sleep and respiratory disorders, is expanding its RD&I facility in Dublin over the next three years.
The IDA Ireland-supported investment will allow ResMed to expand its RD&I facility at its existing operation in NexusUCD, the Innovation Partnerships Centre at University College Dublin.
The new jobs created will facilitate the development of a unique technology platform based on non-contact sensors designed to manage patients with chronic diseases in their home and will be carried through all stages; product standardisation, development of software algorithms, clinical trials and engineering for commercialisation.
It will therefore rank among the most comprehensive medical device development projects ever undertaken by a multinational company’s in Ireland.
“We believe there are great opportunities in growing our presence in Ireland,” ResMed founder, chairman and CEO Dr Peter Farrell explained.
“One of the factors that played a part in our 2011 acquisition of BiancaMed, a UCD spin-out company, was the tremendous advantage of being based in a country that strongly supports research and development.”
Dr Conor Hanley, managing director of ResMed Ireland, said, the investment will allow the company to expand its world class team in Ireland and to continue to drive innovation and develop our technology for better monitoring and care of patients with sleep-disordered breathing and other respiratory disorders.
“This expansion by ResMed Inc is a further endorsement of Ireland’s long established reputation in supporting Research, Development and Innovation,” IDA Ireland chief executive Barry O’Leary said. “Expansions such as this are critical as they embed existing operations and facilitate future investment and job creation.”